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intravenous fluids to inpatients in a teaching
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ABSTRACT: Unnecessary, excessive and poor injection practices in the South East Asia region
(including Nepal) have been observed previously. The authors aim to study prescription of injectable
drugs to inpatients in a teaching hospital in Western Nepal. Prescription of injectable drugs (IDs) and
intravenous fluids (IVFs) to inpatients discharged from the wards of the Manipal Teaching Hospital
during 1st January to 30th June 2006 was studied. The mean number of drugs, IDs and IVFs
administered, median cost of drugs and of IDs/IVFs per prescription calculated. Comparison of ID/IVF
use in the four major hospital departments (Medicine, Obstetrics and Gynecology, Pediatrics and
Surgery) was done. The administration of IDs/IVFs and injectable antimicrobials were measured in
Defined Daily Dose (DDD)/100 bed-days and of Intravenous fluid in Liters (L)/100 bed-days.Of the 1131
patients discharged, 938 (82.94%) patients received one or more IDs/IVFs. The mean number of drugs,
IDs and IVFs prescribed were 8.75, 4.72 and 1.42. Median cost of drugs and IDs/IVFs per prescription
were 8.26US$ and 5.12US$ respectively. IDs/IVFs accounted for 81.37% of total drug cost. The most
commonly used ID, injectable antimicrobial and IVF were Diclofenac (19.3 DDD/100 bed-days),
Metronidazole (7.68 DDD/100 bed-days) and Dextrose normal saline (8.56 L/100 bed-days),
respectively. The total IVF consumption was 24.25 L/100 bed-days. Significant differences between
departments were observed (p<0.05). In conclusion, the use of IDs/IVFs was higher compared to other
studies. Interventions to improve IDs/IVFs prescribing practices may be required.
KEYWORDS: defined daily dose, drug utilization, injectable drugs, inpatients, Nepal, rational use of
medicines. 
INTRODUCTION
Drug utilization research is defined as research on
“the marketing, distribution, prescription and use of
drugs in a society, with special emphasis on the
resulting medical, social and economic consequences”
and has the principal aim of facilitating the rational use
of drugs (1). In developing and transitional countries
(including Nepal), some 16 thousand million injections
are administered each year – a rate of 3.4 injections per
person per year (2). The majority of injections are
unnecessary (3). Reuse of injection equipment in the
absence of sterilization was highest (75%) in the South
East Asia Region (consisting of nine countries including
Nepal) of the World Health Organization (WHO) (2).
The combination of injection overuse and unsafe
practices creates a major route of transmission for
Human Immunodeficiency Virus (HIV), Hepatitis and
other blood borne pathogenic infections (2). 
In order to compare drug utilization among different
countries and even among health institutions within a
country, the ATC and DDD concepts were introduced
(4). The Anatomical Therapeutic Chemical (ATC)
classification system represents a common language for
describing the drug assortment. The DDD is defined as
the assumed average maintenance dose per day for a
drug used for its main indication in adults (4, 5). It
provides a fixed unit of measurement independent of
price and formulation.
A study in the Intensive Care Unit (ICU) from a
teaching hospital in Western Nepal showed that 52.8%
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of drugs were administered by the parenteral route, and
more interestingly 74% of patients were given an
intravenous fluid (IVF) during the period of their ICU
stay (6). A prospective, cross-sectional study of a
tertiary care teaching hospital in Eastern Nepal reported
that 77.7% of the in-patients were prescribed injectable
drugs which constituted 40.4% of the total number of
drugs (7). These studies were either confined to a
particular department or concentrated on a particular
group of drugs.
In view of the high prevalence of use of injectable
drugs (IDs) and intravenous fluids (IVFs), there is an
urgent need to study their utilization. These data are
scant in Nepalese in-patient populations. Knowledge on
how IDs/IVFs are being prescribed and used will be of
immense help in initiating a discussion on their rational
use and suggesting measures to improve prescribing. 
The present study was carried out to obtain baseline
data on prescription of IDs and IVFs to the inpatients.
The objectives of the study were to:
1) Obtain relevant demographic information of 
inpatients of Manipal Teaching Hospital (MTH) 
prescribed IDs/IVFs during the study period.
2) Obtain information on the patterns of prescription 
of IDs/IVFs 
3) Calculate DDD/100 bed-days of the ten most 
commonly used IDs and injectable antibiotics. 
4) Measure IVF utilization in liters/100 bed-days. 
5) Calculate the proportion of the total drug cost 
constituted by IDs/IVFs and 
6)  Analyze and compare the utilization of IDs/IVFs 
between the MTH’s four major departments 
(Medicine, Obstetrics and Gynecology (OBG), 
Pediatrics and Surgery).
MATERIALS AND METHODS:
The study was carried out over a six-month period (1st
January to 30th June 2006) at MTH, a 700 bedded
tertiary care hospital, affiliated with the Manipal
College of Medical Sciences (MCOMS) in Pokhara,
Nepal. The middle ten days of each English month was
selected to minimize the influence of income on
hospital visits.  The period covered five days before
getting salary and five days after getting salary, since
most of the Nepalese people get their salary according
to the Nepalese month which start around the middle of
the English month. To make things clearer, the Nepalese
month of Magh 2065 started on January 14th and will
end on February 11th 2009.   
Records of patients discharged from the various wards
of MTH during the study period were obtained from the
medical records department (MRD) and analyzed.
Inpatients discharged after observation in the
Emergency department and from the Ophthalmology
ward were excluded. Patients admitted for diagnostic
procedures such as endoscopy, hemodialysis etc. and
discharged after the procedure was also excluded. 
Age, Sex, Address, Hospital (patient) number,
Department of Admission, Date of Admission and Date
of Discharge of the patient were recorded. For
calculating the length of stay, the day of admission was
included, while that of discharge was excluded. The
diagnosis written in the discharge summary was noted.
The name, dose, frequency, duration and route of
administration of drugs prescribed during hospital stay
were recorded.
The patients were divided into four age groups (0-1,
1-15, 15-60 and >60 years). Analysis of ID/IVF use in
the four major departments was also done separately.
The department of Medicine runs the Medicine
Outpatient department, Medicine wards, the semi-ICU
and the ICU of the hospital.  The mean number of drugs,
IDs and IVFs administered and their average cost were
calculated. The proportion of total drug cost and of total
drugs (both injectable and non injectable drugs
prescribed to these patients) constituted by IDs/IVFs
were calculated. The cost was calculated by using
Health Information System (HIS), (developed by the
Manipal Corporate office in Bangalore, India) a
computer software program used by the hospital
pharmacy of MTH. The cost refers only to the cost of
drugs and the cost of administration and related fees
was not taken into consideration. The cost was
calculated in both Nepalese rupees and US dollars (one
US dollar (US$) = 78.5 Nepalese rupees (NRs) on 22nd
January 2009). The cost was recalculated to give the
latest conversion figures relative to the US dollar.    
The drugs were classified according to the ATC
system and utilization of IDs was measured in
DDD/100 bed-days and of IVFs in L/100 bed-days.
Injectable drugs (IDs) refer to drugs which were
administered by injection to the patients of the study.
Drugs injected into a peripheral intravenous line were
also considered as IDs.  
The DDD/100 bed-days of the ten most commonly
used IDs were calculated using the following formula
(4):
DDD/100 bed-days   = (Drug consumption in the study
period (mg) × 100)/ (Assigned DDD (mg) × Period of
study × Bed strength × Average occupancy) 
The time period of study was sixty days. There were
583 beds in the wards included in the study and the
average occupancy index was calculated to be 0.299.
Intravenous fluid (IVF) utilization was calculated
using the following formula: Injectable Drug Prescriptions 15 Vol. 12  No. 1
(Liters/100 bed-days) = (Consumption of the particular
IVF during the study period (L) × 100)/ (Period of study
× Bed strength × Average occupancy)
For statistical analysis Statistical Package for Social
Sciences (SPSS) version 10.0 for windows (SPSS Inc.,
Chicago, Illinois, United States) was used. One way
ANOVA was applied to compare means of various
parameters of the four major departments and when
significant (p<0.001) differences were noted, Post hoc
Scheff test was applied.
A pilot study of five days duration (11th to 15th
December 2005) involving 106 patients was carried out
in MTH. The result of the pilot study was not included
in the final analysis and was broadly similar to those
reported here. The instruments used in the study were
standard ones used in previous drug utilization studies.
RESULTS
During the study period, 1131 patients were
discharged, of which 938 (82.94%) received one or
more injection/s during their hospital stay. Percentage
of females receiving injections was slightly higher [481
(51.28% of the total 938 patients receiving injections)]
than males. Seventy-six patients were infants (0-1 year),
131 were children (1-15 years), 521 were adults (15-60
years) and 210 were elderly (>60years). 
Five hundred and ninety-seven (63%) patients were
from Kaski district in which MTH is located. A total of
8203 drugs were prescribed with the mean number
being 8.75. IDs/IVFs accounted for 52.8% of the total
drugs. Mean number of IDs/IVFs was 4.72. A single
ID/IVF was administered to 168 (17.91% of total 938)
patients, while 145 (15.46%) received two such drugs.
Three or more IDs/IVFs were administered to 625
(66.63%) patients. 
The most common conditions for which an ID was
prescribed were hypertension (10.77%), chronic
obstructive pulmonary disease (COPD) (7.78%), acute
gastroenteritis (6.29%) and ischemic heart disease
(6.08%).
Of the 938 patients, who received IDs/IVFs, 535
(57.04%) received parenteral anti-microbial therapy. A
single injectable anti-microbial (IAM) was given to 252
(47.1%) patients, while 161 (30.09%) received two
IAMs. Tables 1 and 2 shows the ATC codes and
DDD/100 bed-days of the ten most commonly
administered IDs and IAMs in MTH respectively. 
A total of 1328 IVFs were administered. IVFs were
administered to 682 (72.71%) of the 938 patients.
Median number of IVF prescribed was one. The total
IVF consumption was 24.25 L/100 bed-days. Table 3
shows the consumption of the most commonly
prescribed IVFs. Median duration of stay was five days;
median cost of prescription and cost of IDs/IVFs in NRs
(US$) were 648.5 ($8.26) and 402 ($5.12). IDs/IVFs
constituted around 81.37% of the total drug cost. No
significant gender variation in administration of
IDs/IVFs was observed, but significant inter-
departmental variation was observed (Table 4).
Significant differences in the median duration of stay
were found between Medicine and OBG (p=0.006) and
Medicine and Pediatrics (p<0.001) with higher duration
of stay in Medicine. The mean number of drugs
prescribed in Pediatrics was significantly (p<0.001)
lower than in Medicine, OBG and Surgery.
IDs/IVFs constituted 40.71% of the total drugs
prescribed and 72.58% of the drug cost in Medicine.  In
Surgery 63.37% of the total drugs prescribed and
74.64% total cost of drugs was due to IDs/IVFs. In
Pediatrics and Surgery, 56.71% and 66.78% of total
prescribed drugs and 87.26% and 88.78% of the total
cost of drugs were due to IDs/IVFs
The mean number of IAMs prescribed in Medicine,
OBG, Pediatrics and Surgery were 0.71, 1.72, 1.09 and
1.69, respectively. In Pediatrics, Medicine and Surgery,
51, 48 and 44% of patients, respectively received at
least one IAM. Table 4 compares frequency of IAM use
in the four major departments. Types of antimicrobials
prescribed in the four departments were similar except
that coamoxiclav (Amoxicillin-Clavulanic acid fixed
dose combination (FDC)) prescription was significantly
higher in Medicine than in the other three departments.
Ciprofloxacin (32%) and a combination of three anti-
microbials (Beta lactams, Gentamicin and
Metronidazole) (44%) was prescribed more in OBG
compared to the other three departments.
Median number of IVFs prescribed in Medicine,
OBG, Pediatrics and Surgery were one, one, one and
two respectively. Table 4 compares frequency of
prescription of various IVFs in the four departments.
Dextrose normal saline (DNS) was the most
frequently administered IVF in the department of
Medicine. In Surgery, Ringer lactate (RL) was most
frequently administered. But RL and Isolyte P were the
most frequently administered IVF in the department of
OBG and Pediatrics, respectively.
DISCUSSION
In this study, a total of 938 (82.94%) of the 1131
inpatients, discharged during the study period, received
at least one injection during their hospital stay. This
result is comparable to that reported from Eastern Nepal
(7), where 77.7% of total inpatients had received IDs
(note: IVFs were not included). In another study from
Ghana, 60% of the patients received one or more
injectable drugs (8). This may indicate higher rate of
injectable administration in MTH. This maybe a matter
of concern and the reasons for this should be16 2009
Name of Anti-
microbial ATC Code4 Frequency
% of
patients
prescribed
(N=535)
DDD/ 100
bed -days
Metronidazole J01X D01 169 31.59 7.68
Gentamicin JO1G B03 159 29.72 3.53
Ampicillin J01C A01 147 27.48 5.22
Cefotaxime J01D A10 147 27.48 2.41
Ceftriaxone J01D A13 75 14.02 3.66
Ciprofloxacin* J01M A02 71 13.27
3.77
(2.41 O;
1.36 P)
Cloxacillin J01C F02 64 11.96 3.15
Coamoxiclav J01C R02 47 8.79 7.26
Amikacin J01G B06 43 8.04 1.25
Cefazolin J01D A04 33 6.17 0.35
Table 2: ATC codes and DDD/ 100 bed-days of the ten most
commonly used injectable anti-microbials (IAMs) in the study.
*A single patient may have been prescribed more than one injectable
preparation.
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investigated in detail.
The local patients frequently visit MTH for their
illness, so the patients receiving injections [597
(63.65%)] were mostly from Kaski district. District
wise distribution of patients visiting MTH is similar to
that noted in previous studies (6,9) done at MTH. Nepal
being a mountainous country, problems of accessibility
to health care services is an important issue.
The median duration of hospitalization was five days.
In a previous study (10) at MTH, median duration of
stay was higher than that reported in the present study
(nine days). On comparison between departments, mean
duration of stay was highest in Medicine followed by
Surgery.  In a previous study (6) in the ICU of MTH, the
mean ± SD duration of hospitalization was 3.84 ± 3.14
days, which is lower than that reported from the
medicine ward (7.89 ± 6.34) in the present study. Once
a patient’s condition improves, they are shifted to other
wards and this may be the reason for shorter ICU stay.
The patients are generally unwilling to stay in the
hospital after IDs have been stopped (11, Personal
observation of the authors and other healthcare
providers). Economic considerations may be partially
responsible for the desire to continue further treatment
at home (11). Decreased use of IDs/IVFs will decrease
the duration of stay and the costs associated. As stated
previously (11) early switchover to oral preparations
should be considered. Formulation of standard
treatment guidelines and an antibiotic use policy in our
hospital is in progress.  
The mean number of drugs administered was 8.75. In
a study from eastern Nepal (7), mean number of drugs
was 5.3 and this figure would have been higher if IVFs
were counted as drugs. A study by Shankar PR et al (10)
in MTH reported the mean number of drugs to be 7.41,
which is less than this study. Another study in Ghana (8)
showed an average of 3.6 drugs prescribed per patient.
Increased administration of IVFs may be a factor partly
responsible for the increase in the mean number of
drugs. The average number of drugs should be kept as
low as possible to minimize the risk of drug
interactions, development of bacterial resistance and
hospital cost (12). 
The average number of drugs was significantly higher
in OBG (10.6) compared to the other three departments.
Normal delivery and Lower Segment Cesarean Section
were the most frequent clinical conditions for the
admission to the OBG ward. In these conditions,
multiple drug prescribing was common. Prescribing of
more than one antimicrobial is also more frequent in
OBG. In Medicine, the mean number of drugs was 9.56
which is less than that reported from Tribhuvan
University Teaching Hospital (13) but higher than that
reported from Harare (14). Elderly patients and patients
Name of
Injection ATC Code4 Frequency 
% of
patients
prescribed
(N=938)
DDD/ 100
bed-
days
Diclofenac M01A B05 228 24.31 19.3
Ranitidine A02B A02 212 22.6 15.65
Metronidazole J01X D01 169 18.02 7.68
Gentamicin JO1G B03 159 16.95 3.53
Ampicillin J01C A01 147 15.67 5.22
Cefotaxime J01D A10 147 15.67 2.41
Metoclopramide A03F A01 128 13.65 3.65
Promethazine R06A D02 115 12.26 6.86
Tramadol N02A X02 106 11.3 2.11
Pethidine N02A B02 102 10.87 0.58
Table 1: ATC codes and DDD/100 bed-days of the ten most
commonly used injectable drugs (IDs) in the studyWestern Nepal 17 Vol. 12  No. 1
with multiple conditions comprised the majority of
patients being treated in the Medicine wards. This might
be the reason for the greater average number of drugs in
Medicine. In this study, it has been found that
significantly lower number of drugs were used in
Pediatrics (5.43) compared to other departments. Even
though mean number of drugs prescribed in Pediatrics
was less, the value is higher than the mean of 3.45
reported in a previous Zimbabwean study (15). But the
result is comparable to the previous studies (9, 16) done
in Nepal. 
Of the total drugs prescribed, 53.98% were IDs/IVFs.
This is very similar to that observed in a previous study
(6) in MTH but higher than that reported from a study
from eastern Nepal (7). In the present study, 17.91%
patients were administered a single injection, while
15.46% were administered two injections. The average
number of injectable drugs should be kept as low as
possible, to reduce poly-pharmacy, cost and hazards
associated with the practice of injectables (17,18).
Mean number of injections administered was lowest in
Pediatrics followed by Medicine. But mean number of
IDs used is higher than that observed previously (1.68)
(16). The percentage of patients receiving IVFs was
69.96% in Medicine (lower than that reported earlier)
(13). Among the four departments, OBG administered
IVFs to highest percentage of patients (82.65%). The
median number of IVFs used was higher in Surgery [2]
compared to the other three departments. This is less
than the median number of IVF prescribed [3] in a study
from Spain (19). The utilization of IVF was 24.25 L/100
bed-days which is similar to the utilization in the ICU
(6). Although DNS was the most commonly prescribed
IVF in the MTH and in Medicine department, RL was
the most frequently administered IVF in surgery and
OBG. In OBG, RL was used as a vehicle to administer
Oxytocin. This is different from that reported in other
studies (20,21). The first study (20) was carried out
among post-operative surgical patients while the second
studied various fluid maintenance therapy regimens in
adult inpatients admitted to the general surgery ward
over a one-year period.  In a hospital in Serbia, Europe
utilization of IVFs varied from 89 to 94 DDD/100 bed-
days (22). Further studies on IVF utilization are
required in MTH. An old study had looked at use of IVF
among medical inpatients in hospitals in the United
States, Scotland, New Zealand, Israel and Canada (23).
Wide variations in the use of IVFs were noted. The use
was maximum in US and least in Scotland and Israel.
The percentage was 53.7% in the hospital with highest
use. The present study shows a use ofa round 70%. The
study (23) was published in 1977 and the passage of
time makes it difficult to draw conclusions.  
Median cost of drugs and IDs/IVFs per patient was
8.26US$ and 5.12US$. However, the cost was higher
than the mean cost of drugs observed previously (9)
among pediatric inpatients who are less likely to suffer
from multiple diseases. The cost of the prescription (and
treatment) is an important variable in determining
accessibility and concordance to treatment especially in
Nepal where the per capita income is 260US$ per year
(24). MTH is a private sector health care provider where
most of the patients have to pay for their treatment and
medicines. But, to make the treatment accessible to
patients belonging to low socioeconomic groups, the
Poor Patient Fund (PPF) has been created and MTH
organizes free treatment service ‘camps’ outside the
hospital. These are health check up programs conducted
by the hospital in outside locations. These could either
be within Pokhara city, within the valley or outside
IAMs were prescribed in 57% of the patients. In a
study from western Nepal (12), 51% of the patients
were prescribed injectable antibiotics. In an Indian
study (25), 42.5% of patients were prescribed
antibiotics parenterally. Similarly, in an Israeli study
(26), 64% of patients were prescribed antibiotics
parenterally. Apart from the cost associated with the
injection procedure, IAMs are themselves costly. Early
Type of
IVF Frequency
% of Total
IVFs
(N=1328)
% of
patient
receiving
injection
(N=938)
Liters/ 100
bed-days
Dextrose
Normal
Saline
(DNS) 387 29.14 41.26 8.56
Ringer
Lactate
(RL) 330 24.85 35.18 5.77
Normal
Saline (NS) 260 19.58 27.72 5.3
5%
Dextrose 132 9.94 14.07 2.29
Isolyte P 85 6.4 9.06 1.27
10%
Dextrose 76 5.72 8.1 0.82
Mannitol 24 1.81 2.56 0.12
Others 34 2.56 3.62 0.12
Total 1328* 100 - 24.25
Table 3: Utilization of Intravenous Fluids (IVFs) 18 2009 McGill Journal of Medicine
switch over from IAMs to oral antimicrobials can
decrease the financial burden. An implementation
program promoting early switch over from intravenous
to oral quinolones ensured a total hospital saving of
41420US$ during the time period considered (27).
Similar programs could be implemented in MTH for
cost effective use of IDs/IVFs.
Ampicillin and Cloxacillin FDC was defined to be
irrational by the Drug and Therapeutics Committee of
MTH and was not available in the MTH pharmacy. But,
still a few prescriptions contained FDC. Coamoxiclav
was the most commonly prescribed injectable FDC
anti-microbial. Furthermore, it was found that a
combination of three anti-microbials (betalactam,
aminoglycoside and metronidazole) was often
prescribed to patients. Educational interventions to
reduce the prescription of coamoxiclav are underway
and managerial interventions are being planned. The
process of framing a hospital formulary is also in
progress. 
Departmental comparison showed the average
number of IAMs prescribed was highest in OBG
followed by Surgery, Pediatrics and Medicine. The
lower mean does not signify that prescription of anti-
microbials is lowest in Medicine because anti-
microbials might have been used orally. Generally,
prophylactic antibiotics were given parenterally in OBG
and Surgery and that might be one of the reasons for the
higher mean number of IAMs in these departments. 
To prevent injection-associated infections, injection
use needs to decrease and injection safety must be
achieved (28). Several interventions were conducted
world wide to decrease injection overuse and/or to
achieve safer practice (28,29). Some of them were very
successful. Better communication between prescriber
and patients and managerial approaches (i.e. restricting
access to selected unnecessary and dangerous injectable
drugs) can reduce overuse (28). The authors of a study
conducted among private sector injection providers
(pharmacies/medical shops and other venues) in the
central region of Nepal (30) found unnecessary and
unsafe use of injections to be common. Adverse effects
like abscesses were common, unsafe handling and
disposal of injection equipment and sharps is common
and reuse of non-sterile injection equipment with the
same patient was commonly observed. Providers failed
to wash their hands or take other precautions while
injecting and recycling waste was a problem (30).
Certain of the problems mentioned may also be
applicable to the hospital setting.       
Parameters Department
Medicine OBG Pediatrics Surgery
Duration (days)
7.89    (6.34) 5.57    (4.43) 5.53    (3.82) 6.65    (6.04)
Number of drugs
9.56    (5.13) 10.60    (4.72)
5.43    (3.77) 9.86    (5.64)
Number of injections
3.89    (3.08) 7.14    (4.21)
3.08   (2.78) 6.58   (3.94)
Frequency (percentage of total prescriptions for IAMs in the particular department)
(N=104)                               (N=72) (N=103) (N=154)
No. of IAMs
1 50 (48.08) 18 (25.00) 53 (51.46) 67 (43.51)
2 37 (35.58) 20 (27.78) 31 (30.10) 44 (28.57)
≥ 3 17 (16.34) 34 (47.22) 19 (18.44) 43 (27.92)
Frequency (percentage of total prescriptions for IVFs in the particular department)
(N=184) (N=81) (N=89) (N=163)
Intravenous fluids
Dextrose Normal Saline
(DNS) 122 (66.3) 38 (46.91) 4 (4.49) 114 (69.94)
Ringer Lactate (RL)
27 (14.67) 76 (93.83) 12 (13.48) 136 (83.44)
Normal Saline (NS) 101(54.89) 12 (14.81) 6 (6.74) 93 (57.06)
5% Dextrose 20 (10.87) 37 (45.68) 0 (0) 42 (25.77)
10% Dextrose 15 (8.15) 1(1.23) 52 (58.43) 7 (4.29)
Isolyte P 0 (0) 0 (0) 67 (75.28) 8 (4.91)
Others 21(11.47) 1(1.23) 2 (2.25) 19 (11.66)
Table 4: Comparison of various parameters, frequency of injectable antimicrobial (IAM) use and use of intravenous fluids (IVFs) among four
major departments of MTH Injectable Drug Prescriptions 19 Vol. 12  No. 1
In the West, the need for parenteral therapy is an
indication for hospitalization. Patients managed with
other agents are treated as outpatients saving money for
the healthcare system. In Nepal, patient demand for
injections, and the inappropriate use of injections are a
common health problem (31). Parenteral therapy is
often started and maintained for the satisfaction of the
patient, because of the patients’ expectations of quicker
recovery and for satisfying patient demand (Personal
observation of the authors). So the issue of parenteral
drug treatment in Nepalese hospitals should be studied
in more detail. 
Our study had many limitations. The study describes
the pattern of injectable utilization, but did not
investigate the reasons why. The study was carried out
over a six month period (during the winter and summer
months) and seasonal variations in disease pattern and
drug utilization were not considered. A study of one
year duration can offset the effect of seasonal variations.
Drugs used for induction and maintenance of
anesthesia, which are generally more expensive than
drugs for many other uses, were also not considered but
this was due to lack of proper documentation. Only the
drug costs were considered and other costs were not
taken into consideration. We did not look for the
frequency of needle stick injuries among health
workers. Follow-up of the patients and their opinion
regarding the injectable use was not done and the
rationality of drug use in different conditions was not
assessed.
CONCLUSION:
The study provides an overview about utilization of
IDs/IVFs among inpatients in MTH and could serve as
a basis for further research, which will help prescribers
to improve patient management by rationalizing
injection practices. The high rate of prescription of
IDs/IVFs is a matter of concern. Decreasing the
prescription and early switch over to oral preparations
will significantly reduce both the drug and non-drug
cost (cost of injection, surgical items and hospital &
nursing charges). Guidelines for the prescription of
injectable drugs (including IAMs) are required.
ACKNOWLEDGEMENTS
We acknowledge the help of Mr. Resham Thapa of the
Medical Record Department (MRD), MTH and other
staff of the department in carrying out the study. The
help of Mr. Arjun Shrestha and his team of the Central
Library, MCOMS, in searching relevant literature for
the study is also gratefully acknowledged.
REFERENCES
1. World Health Organization. Introduction to Drug Utilization
Research. Oslo: World Health Organization; 2003.
2. Hutin YJF, Hauri AM, Armstrong GL. Use of injections in
health care settings worldwide, 2000: Literature review and
regional estimates. BMJ. 2003; 327: 1075-1079.  
3. World Health organization (WHO). Guiding principles to ensure
injectable device security. Safe Injection Global Network
(SIGN) Secretariat, Department of essential Health Technology;
WHO: 2003.
www.who.int/injection_safety/WHOGuidPrinciplesInjEquipFin
al.pdf. Accessed on January 23rd, 2009. 
4. World Health Organization Collaborating Center for Drug
Statistics Methodology. Guidelines for ATC classification and
DDD assignment 5th ed. Oslo: World Health Organization;
2001.
5. World Health Organization Collaborating Center for Drug
Statistics Methodology. ATC index with DDDs 2009. Oslo:
World Health Organization; 2008.
6. Shankar PR, Partha P, Dubey AK, Mishra P, Deshpande VY.
Intensive Care Unit Drug Utilization in a Teaching Hospital in
Nepal. Kathmandu Univ Med J. 2005; 3; 130-137.
7. Rehana HS, Nagarani MA, Rehan M. A study on the drug
prescribing pattern and use of antimicrobials at a tertiary care
teaching hospital in eastern Nepal. Indian J Pharmacol. 1998;
30:175-180.
8. Bosu WK, Ofori-Adjei D. A 1 day survey of drug prescribing
patterns in the District General Hospital of the Wassa West
District of Ghana. Trop Doct. 1997; 27: 222-226.
9. Shankar PR, Upadhyay DK, Subish P, Dubey AK, Mishra P.
Prescribing pattern among paediatric inpatients in a teaching
hospital in western Nepal. Singapore Med J. 2006; 47: 261-265.
10. Shankar PR, Subish P, Upadhyay DK, Dubey AK, Deshpande
VY. Cephalosporin utilization in the in-patient wards of a
teaching hospital in western Nepal. Pharmacoepidemiol Drug
Saf. 2005; 14: 507-508.
11. Shankar PR, Partha P, Shenoy N, Joshy ME, Brahmadathan KN.
Prescribing patterns of antibiotics and sensitivity pattern of
common microorganisms in the internal medicine ward of
teaching hospital in western Nepal: a prospective study. Ann
Clinical Microbiol Antimicrob 2003; 2:7.
12. Stratton CW 4th, Ratner H, Johnston PE, Schaffner W. Focused
microbiological surveillance by specific hospital unit: practical
application and clinical utility. Clin Ther. 1993; 15 suppl A: 12-
20.
13. Joshi MP, Sugimoto T, Santoso B. Geriatric prescribing in the
medical wards of a teaching hospital Nepal. Pharmacoepidemiol
Drug Saf. 1997; 6: 417-421.
14. Nhachi CF, Zvaraya P, Kasilo J. Drug utilization in the geriatric
population in the nursing homes and central hospitals of urban
Harare. Cent Afr J Med. 1994; 40:126-131.
15. Nhachi CF, Kasilo OM, Nathoos S. Drug prescribing in
paediatric in-patients at Harare and Parirenyatwa Central
Hospitals. Cent Afr J Med. 1992; 38: 57-62.
16. Rauniar GP, Rani MAN, Das BP, Singh R. Prescribing pattern of
antimicrobial agents in Pediatric inpatients. J Nepalgunj Med
Coll. 2003; 3: 34-73.
17. Hersh BS, Popovici F, Jezek Z, et al. Risk factors for HIV
infection among abandoned Romanian children. AIDS. 1993; 7:
1617-1624. 
18. Soeters R, Aus C. Hazards of injectable therapy. Trop Doct.
1989; 19: 124-126.
19. Navarro F, Martinez–Bengoechea MJ , Prieto M , Jaio N ,
Rodrogue Z-Sasiain JM. The extent of sodium ion and water
administration associated with intravenous drug infusions in a
surgical unit. J Clin Pharm Ther. 1994;19: 355-358.
20. Stoneham MD, Hill EL. Variability in post operative fluid and
electrolyte prescription. Br J Clin Pract. 1997; 51: 82-84.20 McGill Journal of Medicine 2009
21. Campo AM, Garcia RP, Martinez DC et al. Use of the
maintenance fluid therapy in Surgery. Farm Hosp. 2004; 28: 84-
89.
22. Jankovic SM, Dejanovic SMD. Drug utilization trends in
clinical hospital center “Kragujevac” from 1997 to 1999. Indian
J Pharmacol. 2001; 33: 29-36.  
23. Lawson DH. Intravenous fluids in medical in-patients. Br J Clin
Pharmac. 1977; 4: 299-303. 
24. The World Bank. Country Overview: Summary of economic
development and World Bank assistance. http://
www.worldbank.org.np. 
25. Gupta M, Malhotra S, Chandra KK, Sharma N, Pandhi P.
Utilization of parenteral anti-infective agents in medical
emergency unit of a tertiary care hospital: an observational
study. Pharmacoepidemiol Drug Saf. 2004;13: 653-657.
26. Raven D, Levy Y, Schlesinger Y, Greenberg A, Rudensky B,
Yinnon AM. Longitudinal surveillance of antibiotic use in
hospital. QJM. 2001, 94: 141-152.
27. Pablos AI, Escobar I, Albinana S, Serrano O, Ferrari JM,
Herreros de Tejada A. Evaluation of an antibiotic intravenous to
oral sequential therapy program. Pharmacoepidemiol Drug Saf.
2005; 14: 53-59.
28. Hutin Y. Recent progress towards the safe and appropriate use of
injections worldwide. WHO Essential Drug Monitor. 2005, 34:
6-7.
29. Zamin HT, Pitre MM, Conly JM. Development of an
intravenous to oral route conversion program for antimicrobial
therapy at a Canadian tertiary health care facility. Ann
Pharmacother. 1997; 31: 564-570.
30. Bhattarai MD, Wittet S. Perceptions about injections and private
sector injection practices in central Nepal.  General Welfare
Pratisthan and Gate’s Children’s Vaccine Program at PATH.
December 2000.  http://www.path.org/files/Nepal-Inject-
Practices-RA.pdf. Accessed on January 23, 2009. 
31. INRUD, Nepal. 16th National Training Course on Rational Use
of Drugs. INRUD Training Manual Series (Revised, English) -
13. 